Company / Current Assets
Kura Oncology, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$708.7M
FY2025
5-year range
$432.5M / $744.8M
FY2021-FY2025
Trend
-4.9%
vs FY2024
Sector context
#81 of 213
Health Care
What the data says
At $709M, Kura Oncology, Inc.'s current assets ranks #81 of 213 in the Health Care sector. Current Assets has fluctuated over the past 10 years, ranging from $69M in FY2016 to $745M in FY2024.
Based on SEC 10-K filings.
$709M in FY2025 with a 5-year CAGR of +2.1%.
Improved from $432M to $709M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +16.7%
- 5-Year CAGR
- +2.1%
- 10-Year CAGR
- -
Sector benchmark
#81 of 213 in Health CareTop 38% of 213This company $708.7M Sector average $2.5B
▼
-71.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.1%, indicating consistent growth.
- In FY2025, current assets decreased 4.9% year-over-year.
- Ranks #81 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $708.7M | -4.9% |
| FY2024 | $744.8M | +72.2% |
| FY2023 | $432.5M | -3.1% |
| FY2022 | $446.4M | -14.5% |
| FY2021 | $522.3M | -18.0% |
| FY2020 | $637.3M | +166.0% |
| FY2019 | $239.6M | +32.2% |
| FY2018 | $181.2M | +91.5% |
| FY2017 | $94.6M | +37.5% |
| FY2016 | $68.8M | -20.8% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026